
Wegovy craze was all the rage on Q3 earnings calls
By Bhanvi Satija and Savyata Mishra Weight loss was the talk of this earnings season, making names such
1970-01-01 08:00

Retail investors crowd into Eli Lilly after weight-loss drug approval
By Bhanvi Satija and Amruta Khandekar Retail flows into Eli Lilly spiked to a more than two-year high
1970-01-01 08:00

Wegovy's heart benefits due to more than weight loss, Novo says
By Patrick Wingrove PHILADELPHIA (Reuters) -Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity
1970-01-01 08:00

Eli Lilly: still seeking UK approval on pen for weight-loss drug
By Maggie Fick and Ludwig Burger LONDON Eli Lilly on Thursday said it has not yet gained approval
1970-01-01 08:00

Weight loss drugs transforming healthcare, may help with addiction -Reuters Events
By Julie Steenhuysen and Caroline Stauffer CHICAGO A new class of weight loss drugs is transforming the U.S.
1970-01-01 08:00

Factbox-Corporate America weighs risks of the Ozempic effect
U.S. companies across sectors such as food and beverage makers and manufacturers of glucose monitors have faced investor
1970-01-01 08:00

Novo Nordisk's Wegovy bonanza looms large in Denmark
By Maggie Fick COPENHAGEN The whirlwind success of weight-loss treatment Wegovy is providing a bonanza not just for
1970-01-01 08:00

U.S. FDA found lapses at Novo's main U.S. factory in May 2022 -report
By Maggie Fick LONDON (Reuters) -U.S. drug regulators issued a report detailing quality control lapses at Novo Nordisk's main factory
1970-01-01 08:00

Wegovy makes UK weight-loss debut even as Novo struggles with supplies
By Maggie Fick LONDON Some Britons are set to be able to get Wegovy weight-loss injections after Novo
1970-01-01 08:00

Obesity drug data could boost companies' case for US coverage-analysts
By Patrick Wingrove New data on the heart benefit of an obesity drug from Novo Nordisk increases the
1970-01-01 08:00

Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market
By Ludwig Burger and Maggie Fick FRANKFURT Novo Nordisk has launched blockbuster weight-loss drug Wegovy in Germany, its
1970-01-01 08:00

Lilly's obesity drug leads to about 26% weight loss in new studies
By Bhanvi Satija and Leroy Leo (Reuters) -Eli Lilly said on Thursday its experimental obesity drug helped patients reduce 26.6%
1970-01-01 08:00